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A significant increase in intestinal mucosal cell uptake rate can be achieved by making brush 
border enzyme-labile derivatives of water insoluble compounds. The test compounds chosen 
were decanol, hexadecanol, their corresponding lysinate esters, hydrocortisone and its 
phosphate and succinate esters. Intestinal perfusion and intestinal ring uptake experiments 
in the alcohol study demonstrated that prodrug uptake was comparable to uptake of the 
free alcohol below the solubility of the parent compound; i.e., there was little or no loss in 
intestinal permeability. Prodrug uptake continued to increase linearly above the solubility 
of the free alcohol in the ring system. Similar results were obtained for hydrocortisone and 
its prodrugs when uptake was examined in the intestinal ring system; furthermore, rapid 
post-incubation freezing of the tissue coupled with an HPLC assay capable of separating 
drug from prodrug permitted determination of the species absorbed. In all cases, only free 
alcohol was detected in the tissue. Histological studies verified the integrity of intestinal 
tissue under experimental conditions. The in vitro technique is advantageous for screening 
drug absorption. The very substantial potential of this prodrug approach is demonstrated in 
particular with hexadecanol and hexadecyl lysinate, where the uptake rate of the prodrug 
was four orders of magnitude greater than that of the free alcohol. 
BACKGROUND 
The gastrointestinal absorption of poorly 
water soluble drugs is often erratic and results 
in highly variable blood levels and bioavail- 
ability. In part, this is a function of slow dis- 
solution of the solid which is dependent on the 
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dissolution rate constant, as well as the con- 
centration gradient from the saturated con- 
centration of the drug at the solid surface 
to the bulk concentration in the intestinal 
lumen [l] . For weak acids and bases, lumenal 
concentrations are also a function of pH and 
therefore can be expected to vary along the 
pH gradient in the intestinal tract [2]. In 
addition, individual variation in gastrointes- 
tinal transit times will affect the percentage 
of drug dissolved and hence. the amount 
available for absorption. 
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One solution to the problem of low aque- 
ous solubility is to produce a more polar 
prodrug with resultant higher aqueous solubil- 
ity [ 31. This method generally requires re- 
conversion to the parent drug to obtain the 
original pharmacological activity. The site 
of reconversion in the body is important 
for several reasons: (a) hydrolysis of the 
prodrug to the parent drug and its possible 
precipitation should be minimized prior to 
absorption from the gut; and (b) the dif- 
fusion/transport advantages of the nonpolar 
parent drug through lipoidal membranes 
should not be compromised. 
Under sink conditions in the blood, the 
maximal flux at the absorbing membrane, 
J is limited by the solubility of the com- 
p:und [4] : 
J, = Pe& (1) 
where Peff is the effective permeability and 
C, is the solubility concentration in the 
bulk solution. A prodrug approach which 
addresses the above considerations pro- 
posed [4] a drug derivative designed as a 
substrate for membrane-bound enzymes in 
the small intestine (Fig. 1). With reconversion 
Fig. 1. Proposed mechanism for improving oral ab- 
sorption of water insoluble compounds. 
occurring in close proximity to the mem- 
brane, the higher partition coefficient of the 
parent drug into the membrane should min- 
imize precipitation in the lumen. Further- 
more, the effective permeability of the 
prodrug should not be significantly less than 
that of the drug if the wall reconversion is 
rapid [4] . Of particular significance is the 
high solubility of the prodrug, which increases 
the concentration gradient from the intestinal 
lumen to the wall and therefore the chemical 
driving force for reaction/absorption at the 
wall. Since the solubility of the derivative 
can be orders of magnitude higher than 
that of the parent compound, large increases 
in absorption rate are possible with this 
approach. 
Increased knowledge of the distribution 
and specificities of certain gut digestive 
enzyme systems suggests a prodrug design 
strategy in which the derivative contains 
an enzyme-labile linkage [ 51. Brush border- 
bound enzymes of particular interest for 
site-specific targeting include aminopeptidases, 
dipeptidases [6--S] and alkaline phosphatase 
[9]. Phosphate prodrugs are much more 
water soluble than the parent drugs at in- 
testinal pH due to the negative charges of 
the progroup and are stable in aqueous 
solution [lo] , while amino acid derivatiza- 
tion provides the possibility of a wide range 
of physical property modifications, as well 
as releasing nontoxic substances upon hydrol- 
ysis, Lysine derivatives have been shown to 
be good substrates for intestinal brush border 
aminopeptidase. This was substantiated in 
studies utilizing the in situ rat intestinal 
perfusion system in the presence and ab- 
sence of aminopeptidase inhibitors [ 11, 121. 
These studies observed that a free alpha 
amino group was an essential requirement 
for enzymatic hydrolysis of amino acid 
/3-naphthylamine derivatives. Other strategies 
can be used to increase membrane permeabil- 
ity [5]. For example, Shindo et al. [13] 
demonstrated with the pivaloyloxymethyl 
ester of ampicillin that the high nonspecific 
esterase activity associated with the rat 
intestine was primarily localized in the 
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intracellular compartments of the mucosal 
cell. Pivampicillin was rapidly absorbed 
from the lumen in its intact form and hy- 
drolyzed to ampicillin in the mucosa. The 
strategy presented in this paper, however, 
utilizes phosphate, lysinate and succinate 
progroups to impart a significant polar 
contribution to the prodrug and substantial- 
ly increase aqueous solubility. Water in- 
soluble compounds containing amino, hy- 
droxyl or carboxylic acid moieties are good 
candidates for the drug components. 
In this report the potential of the above 
prodrug strategy is investigated using decanol, 
hexadecanol and hydrocortisone as the parent 
compounds of low aqueous solubility (0.2 
m.iV, 0.2 PM and 0.77 mM, respectively [14] ). 
Lysine esters of both alcohols were synthe- 
sized. Hydrocortisone-21-succinate and 21- 
phosphate were available commercially. Deca- 
no1 and decyl lysinate were tested in an 
in situ rat intestinal perfusion system and 
all seven compounds were examined in an 
in vitro rat intestinal ring system [15, 161 
which allowed study both below and above 
the solubilities of the parent compounds. 
An HPLC assay was developed which re- 
solved the three steroids after extraction 
from tissue. Coupled with rapid, post-incuba- 
tion freezing of the tissue and incubation 
media, this permitted investigation of (a) 
the possibility of bulk prodrug hydrolysis 
or back-diffusion from the membrane, and 
(b) the nature of the species transferred 
into the tissue, i.e., drug or intact prodrug. 
Tissue integrity under the conditions of 
intestinal perfusions, intestinal ring prep- 
aration, incubation and exposure to high 
concentrations of surface-active agent was 
examined. This was accomplished by moni- 
toring extracellular water content and by 
light microscopic evaluation. 
EXPERIMENTAL 
Materials 
1-Decanol, 1-hexadecanol (Aldrich Chem. 
co., Milwaukee, WI), hydrocortisone, its 
21-phosphate disodium salt and 21-hemi- 
succinate sodium salt (Sigma Chem. Co., 
St. Louis, MO) and [ 14C] 1-decanol, [ 14C] l- 
hexadecanol (ICN, Irvine, CA) and [ 14C] PEG 
4000 (DuPont-NEN, Boston, MA) were used 
as received. The internal standard used for 
gas chromatography analysis of decanol 
was l-undecanol and for HPLC analysis of 
the steroids A4-pregnene-17~-200,21-triol-3,11- 
dione. All chemicals were of HPLC or analyt- 
ical reagent grade and used as received with 
the exception of methylene chloride, which 
was purified by glass distillation at 38°C. 
Procedure for the synthesis of radioactive decyl and 





N,N’-Di-t-BOC-L-lysine free carboxylic acid 
(0.2 mmol) and 0.2 mmol of [14C] l-decanol 
or [ 14C] 1-hexadecanol was dissolved in 2 
ml of dichloromethane. To the stirred solu- 
tion at 25°C was added 0.2 mmol of dicyclo- 
hexylcarbodiimide and 0.02 mmol of 4-di- 
methylaminopyridine as an acylation catalyst. 
The reaction was completed in about 10 min 
as shown by TLC analysis (silica gel plate, 
solvent 10% ethyl acetate/dichloromethane) 
which revealed total consumption of starting 
materials and formation of a new major spot. 
Solid materials were removed by filtration 
and the solvent was evaporated to give crude 
material which, after chromatography on 
silica gel (eluting with 10% ethyl acetate/di- 
chloromethane), yielded a colorless oil 
homogeneous by TLC. This oil was dissolved 
in 3-4 ml of anhydrous ethyl ether contain- 
ing gaseous hydrogen chloride to remove 
the t-BOC protective groups from the lysine 
nitrogens. The solution was stirred at 25°C 
for 24 h; the solvent was evaporated under 
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vacuum. Ethyl ether and ethanol were added 
and then removed under vacuum several 
times to remove residual hydrogen chloride. 
Finally, the product was recrystallized 
from a mixture of ethanol and ether. The 
esters obtained in this procedure were the 
dihydrochloride salts. No unreacted decanol 
was detectable in the product using gas 
liquid chromatography. Elemental analysis 
of decyl lysinate (C,6H36N202C12) was cal- 
culated as C = 53.47, H = 10.10, N = 7.79 
and was found to be C = 53.70, H = 10.50, 
N = 7.40. Infrared spectra (Nujol mull, 
Aldrich Chem. Co.) were identical for radio- 
active and nonradioactive analogs, demon- 
strating the NH3 bond at 3300-2800 cm-’ 
and ester carbonyl absorption at 1740 cm-‘. 
droxide. Samples were extracted twice 
with equal volumes of methylene chloride 
containing the internal standard. The ex- 
traction efficiency from buffer was 97.0 
? 0.5% and 93.2 ? 0.7% from plasma. The 
extracts were injected into a Perkin-Elmer 
gas chromatograph, Model 3920 (Norwalk, 
CT) with the injection block set at 230°C. 
The instrument was interfaced with a Nuclear 
Chicago electrometer, Model 7221 (Des 
Plaines, IL) and a Linear recorder (Irvine, 
CA). Detection was by flame ionization at 
250°C. The glass columns were packed with 
Superpak 20M (Analabs Inc., New Haven, 
CT). A 2 min isothermal period at 9O”C, 
followed by a 90-120°C linear ramp at 
2°C min was an optimal temperature pro- 
gram. Nitrogen was the carrier gas. 
In situ rat intestinal perfusion studies 
Calculation of intestinal permeabilities 
Rats were anesthesized with urethane 
(50% w/v, 150 mg/lOO g, IM) after fasting 
for 20-24 h with water ad libitum. The upper 
small intestine was exposed by a midline 
longitudinal incision. A proximal glass can- 
nula was inserted approximately 2 cm below 
the ligament of Treitz and was connected to 
a Harvard withdrawal/infusion pump (Harvard 
Apparatus Co., S. Natick, MA). A second 
cannula was positioned 6-10 cm distal to 
the first cannula for an exit tubing and led 
to a collection tube. 
Sorenson’s phosphate buffer (pH 7.2) 
was perfused through the intestine for 30 
min at a flow rate of 0.247 or 0.382 ml/mm 
This was immediately followed by perfusion 
at the same flow rate of decanol or freshly 
prepared decyl lysinate/buffer solutions (non- 
radiolabeled) at concentrations below the 
solubility of decanol. These solutions were 
perfused 60-75 min with collection over 
15 min intervals. 
Gas chromatography analysis of decanol 
Perfusate samples containing decyl lysinate 
were analyzed for decanol content after 
alkaline hydrolysis with 1 N sodium hy- 
Effective permeability values, P,ff, were 
obtained from the experimentally obtained 
C, /C, values by the following relation 
J%ff = [ln G/Co)ex,l /-4Gz (2) 
where G, is nDL/2Q, L is the intestinal 
length, D is the diffusion coefficient [ 171, 
Q is the flow rate, and C&,/C, is the ratio 
of perfusate concentration exiting the in- 
testine to the concentration of the inlet 
tubing. 
Aqueous permeability values, ‘P&, were 
calculated from the analytic solution of the 
mass balance equation [ 181 
“P& = [In (cm /co), 1 /m-4% (3) 
(‘%!co)th = 5 ‘Mn exp( -“Bi G,) (4) 
n=l 
where ‘M,,, ‘B, are functions of the wall 
permeability, ’ and * indicate sink conditions 
and dimensionless quantities, respectively, 
and (C, /C,,)th represents the theoretical 
value calculated for exiting to inlet con- 
centrations [ 191. 
“PG may be separated from the effective 
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permeability using a series resistance sum 
for the radial transport of solute in the 
intestine assuming laminar flow [4,19] : 
Gf =R&+R; (5) 
where the resistance, R, is the reciprocal 
of the permeability. When “P”;v % ‘P&, the 
method becomes insensitive to the actual 
“Pl;, value [4]. 
In vitro intestinal ring studies 
Male rats, fasted 24 h with water ad libi- 
turn, were sacrificed by anoxis. Fifteen to 
20 cm of upper small intestine (jejunum) 
was removed immediately, placed in oxygen- 
ated Krebs-Henseleit buffer and everted on 
a glass rod. Incubations were performed 
in a shaking water bath at 37°C 90 cycles/ 
min, in oxygenated solutions containing the 
solutes of interest. Saturated solutions of 
the parent alcohol of steroid were equili- 
brated 20-24 h prior to incubation with 
tissue. Prodrug solutions were freshly pre- 
pared. Incubation times were set at 2-5 min. 
The incubation was stopped by emptying 
the test tube contents onto a cheesecloth- 
covered beaker. The tissue was rinsed with 
cold buffer and blotted dry. Subsequent 
determination of tissue uptake differed for 
alcohols and steroids since the former and 
their prodrugs were available as radiolabeled 
compounds. In this case, the tissue was 
weighed in a tared vial, solubilized with 
0.5 ml 30% KOH plus 15.0 ml Scintiverse II 
(Fisher Scientific, Fair Lawn, NJ) and counted 
by a LS 7500 scintillation counter (Beckman 
Instruments, Berkeley, CA). Uptake was ex- 
pressed as nmol/min g wet tissue after subtrac- 
tion of background activity obtained from 
tissues not exposed to radioactivity. An 
HPLC assay was developed for analysis of 
hydrocortisone, its 21-phosphate and 21- 
succinate esters taken up by intestinal tissue. 
After sampling of the incubation medium 
and rapid freezing of the post-incubation 
tissue to prevent further ester hydrolysis, the 
samples were transferred to a VirTis freeze- 
dryer (Gardiner, NJ) and sublimated for 48 h. 
The dry tissue weight was measured and, after 
pulverization, the powder was acidified with 
formic acid and extracted three times with 
ethyl acetate. The three extracts were com- 
bined and dried under nitrogen. The residue 
was reconstituted with acetonitrile and cen- 
trifuged prior to HPLC injection. [ 14C] Hydro- 
cortisone was used in concert with HPLC 
analysis to verify that no residual drug re- 
mained in the white precipitate formed by the 
addition of ethyl acetate to the acidified 
tissue powder. Blank tissues were processed as 
controls for endogenous hydrocortisone levels 
in gut tissue. Results were expressed as nmol/ 
min g dry tissue. 
HPLC analyses of hydrocortisone, its 21-phosphate 
and 21-succinate esters 
All HPLC analyses were conducted at 
254 nm. The mobile phase consisted of 
33% acetonitrile, 67% acetate buffer (6.8 
g/l) and was adjusted to pH 3.8 with 50 
ml glacial acetic acid/l. A 10 I.tm, RP-18 
Hibar II LiChrosorb column (E.M. Reagents, 
Gibbstown, NJ) was fitted with a RP-18 
guard column (Anspec Inc., Ann Arbor, 
MI). The instrumental system consisted of 
a Waters Intelligent Processing System, 
Model 710B (Milford, MA) interfaced with 
a Spectroflow 773 Absorbance Detector 
(Kratos, Ramsey, NJ), Beckman 112 Solvent 
Delivery Module (Berkeley, CA) and Hewlett- 
Packard 3390A Integrator (Avondale, PA). 
Statistical treatment of tissue uptake results 
Tissue uptake of solute at the same concen- 
trations were pooled from individual rings 
and different rats. The mean +- the standard 
error of the mean (SEM) and linear regression 
parameters, as applicable, are reported. 
Tissue integrity under experimental conditions 
Tissue handling and incubation times were 
deliberately minimized in order to promote 
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tissue viability. Tissue integrity was assessed 
by two means. Extracellular water (ECW) 
changes were examined using [ 14C]PEG 
4000 in the incubation medium of the fol- 
lowing (all incubations at 37°C) to monitor 
development of mucosal cell leakiness [ 151 : 
(a) controls, incubated with buffer for 3, 
6 and 12 min; 
(b) 0.25, 0.40 and 0.55 mit4 hydrocortisone 
solutions incubated for 6 min; 
(c) 0.25 mM hydrocortisone solutions in- 
cubated for 3, 6 and 12 min. 
Each test solution or time was performed in 
triplicate and analyzed by the method de- 
scribed for the radioactive alcohols and 
lysinate prodrugs. In addition, the following 
specimens were prepared for light microscopy 
evaluation of both in vitro ring technique 






control, unperfused intestinal segment; 
intestinal segment perfused for 1 h with 
buffer, 0.382 ml/min; 
everted intestinal ring prepared and 
immediately fixed; 
everted intestinal ring incubated in buffer 
for 5 min; 
everted intestinal ring incubated in 0.25 
m&f hydrocortisone-21-succinate for 5 
min; 
the same as (e) but 10 mM hydrocorti- 
sone-21succinate. 
Specimens were fixed in Bouin’s solution 
for at least 24 h, then dehydrated, cleared 
and embedded in paraffin [20] . Sections of 
8-10 I.trn thickness were made and stained 
with hematoxylin and eosin. 
RESULTS AND DISCUSSION 
Tissue integrity studies 
Extracellular water content, as determined 
by the nonabsorbable marker, [ 14C] PEG 
4000, did not change over the time course 
of the experiments regardless of whether 
the intestinal tissue was incubated with 
buffer or different concentrations of hydro- 
TABLE 1 
Extracellular water content of jejunum under the 
experimental conditions of the in uitro intestinal 
ring procedure. All incubations were performed at 
37°C. This experiment monitored any changes in 
intestinal tissue leakiness (HC = hydrocortisone.) 
Sample ml ECW/g tissue 
Control, 3 min 0.206 + 0.100 
Control, 6 min 0.269 + 0.044 
Control, 12 min 0.323 ?r. 0.123 
0.25 r&f HC, 3 min 0.146 ? 0.048 
0.25 r&l HC, 6 min 0.488 * 0.105 
0.25 mM HC, 12 min 0.204 * 0.035 
0.40 m&f HC, 6 min 0.203 * 0.038 
0.55 mM HC, 6 min 0.271 t 0.096 
cortisone (Table 1). Calculations based on 
tissue weight before and after freeze-drying, 
and results from [ 14C] PEG 4000 experiments 
indicate that jejunal tissue is approximately 
80% water. This translates into about 20 ~1 
total water/ring, of which 30% is extracel- 
lular water. 
The results obtained from histology studies 
performed under in situ and in vitro experi- 
mental conditions are presented in Figs. 2 
and 3. Figure 2A is a control specimen 
taken from normal rat intestine. It is con- 
trasted with Fig. 2B, which shows the im- 
pact of in situ buffer perfusion through 
the intestine of the same animal for 1 h. 
Swelling of the central lacteals of the villi 
is present in the perfused segment, with some 
reduction in intervillus space probably due 
to water absorption. This has been noted 
for rabbit intestine when lengthy incubation 
times were used in vitro [21] . The micro- 
graph serves to show, however, that in this 
steady-state experimental system the func- 
tional integrity of the villus is maintained. 
When examined at higher magnification, 
this is also true for the brush border (Fig. 2C). 
The micrographs presented in Fig. 3 
evaluate tissue viability during the in vitro 
intestinal ring method. The first panel, Fig. 
3A, illustrates the structural condition of 
the intestine immediately after it has been 
Fig. 2. Normal rat intestine is shown in panel A, 
while panel B depicts the effect of a 1 h intestinal 
perfusion of phosphate buffer in the same animal. 
In the higher magnification in panel C, it can be 
seen that integrity of the brush border is maintained. 
excised and everted. The three subsequent 
panels (Figs. 3B-D) show intestinal seg- 
ments which have been incubated for 5 min 
with either buffer or hydrocortisone-21- 
succinate, with a higher magnification of 
the higher steroid concentration depicted 
in Fig. 3E. There appears to be no solute 
effect at the light microscopy level. The 
effect of incubation at 37°C appears to be 
a slight thickening of the villi with crowding 
of the intervillus spaces and, therefore, some 
change in the surface area available for ab- 
sorption. Swelling of the central lacteal is 
not evident here as it was in the perfused 
segment, probably due to the short time 
course of the experiment. Again, the gross 
structures of the villi are maintained as 
well as the integrity of the brush border. 




Effective intestinal permeabilities obtained from rat 
perfusions in situ conducted below the solubility of 
decanol (0.2 r&f). Graetz numbers were in the 
range of 0.01-0.04. 
Compound P& (37”C)a Solubility 
l-decanol 5.35 f 0.28 (n = 6) 0.2 mA4 
decyl lysinate 3.38 * 0.50 (n = 7) >2omM 
Fig. 3. Panel A shows the condition of the intestine 
after eversion and immediate fixation. Panels B, C 
and D depict specimens incubated for 5 min at 
37°C in Rrebs-Henseleit buffer, 0.25 m&f and 
10.0 mM hydrocortisone-Zl-succinate, respectively. 
Panel E is a higher magnification of D. 
meabilities for decanol and decyl lysinate 
are summarized in Table 2. The wall per- 
meabilities, “Pk , were very high for both 
compounds and it is more instructive to 
note that the effective permeabilities of 
both compounds are very close. The solu- 
tion hydrolysis kinetics of decyl lysinate 
were followed in perfusate and found to 
be first-order (r = 0.99), with a rate constant 
of 0.0025 min-‘. The corresponding half- 
life is 277 min which is long with respect 
to the intestinal residence time, 
t = n2r2/Q (6) 
of 3.2 min, where I is intestinal length, r is 
intestinal radius, and Q is flow rate. Con- 
sequently, solution hydrolysis followed by 
absorption is unlikely. It can be concluded 
therefore, that while the aqueous solubility 
aP& (dimensionless) = (R/D)P,, are effective per- 
meabilities (cm/s) normalized by the ratio of intes- 
tinal radius (cm) to compound aqueous diffusivity, 
P& = 5.25 = (0.2 cm/887 X 1O‘6 cm’/s)-(2.37 
x 10e4 cm/s). 
of decanol has been increased by at least a 
factor of 100 by esterification with lysine, 
the permeability has not been si~ific~tly 
compromised. It would be unlikely to ob- 
serve comp~able permeabiliti~s between 
two compounds of such different polarity 
(Le., hydrocarbon vs. ionized species) unless 
hydrolysis of the prodrug has occurred prior 
to absorption. 
The significance of the prodrug’s increased 
solubility without a compromise in intestinal 
permeability was further investigated in an 
in vitro intestinal ring system using radio- 
labeled tracers [ 15, 161. This method per- 
mitted study of the uptake process above 
the solubilities of the two parent alcohols, 
decanol and hexadecanol. In addition, the 
in vitro method used short incubation times 
which maintained tissue integrity, and was 
advant~eous statistically since a large number 
of data points could be obtained from the 
same experimental animal. 
The mean uptake by intestinal rings is 
shown for decanol and decyl lysinate as a 
function of concentration in Fig. 4. At con- 
centrations below the solubility of decanol, 
the slopes of both curves are comparable, 
providing agreement with the intestinal per- 
meabilities obtained from in situ perfusions 
in the same concentration range. Differences 
in uptake rate increase rapidly with concen- 
tration since the parent alcohol remains at 
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CONCENTRATION (UM) 
Fig. 4. The intestinal ring uptake of decanol (0) and decyl lysinate (0) as a function of concentration. Values 
above the solubility concentration of decanol are indicated by l . Each point represents the mean value of 2-9 
intestinal rings from 2-3 rats I SEM. 
the plateau dictated by its lower solubility 
(0.2 rnM) and the lysinate ester maintains a 
linear increase in uptake over the entire con- 
centration range studied. 
Figure 5 depicts a summary of logarithmic 
intestinal ring uptake of the four compounds 
at selected concentrations. Values for hexa- 
decanol and decanol are at the respective 
solubility concentrations or slightly below 
(0.2 PM and 0.15 ti, respectively). The 
logarithmic differences correspond well with 
what would be expected on an order-of- 
magnitude basis given the concentrations 
in the incubation medium. The increased 
aqueous solubilities of the lysinate esters 
demonstrate the impact of a greater concen- 
tration gradient on uptake rate at concen- 
trations at least 10X in excess of the solubil- 
ities of the parent compounds. Figure 5 
clearly demonstrates that this prodrug ap- 
proach can be used to greatest advantage for 
very water insoluble compounds. 
Intestinal ring experiments were also con- 
ducted with hydrocortisone, the 21-phos- 







I4 D HL 
200 PM 150 UM 1.5 mM 
DL 
2.0 mM 
Fig. 5. Logarithmic uptake rates by intestinal rings 
at selected concentrations. The uptakes are shown 
at the solubility of hexadecanol (H), slightly below 
the solubility of decanol (D), and well below the 
solubilities of the lysinate esters (HL, DL). 
in situ/in vitro correlation and (b) ascertain 
whether drug or prodrug is being absorbed 
into intestinal tissue. Hydrocortisone was 
the only species detected in jejunal tissue 
by HPLC analysis, whether the rings were 
incubated with drug or prodrug. Unpub- 
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UPTAKE of HYDROCORTISONE and ITS ESTERS 
SUCCINATE and PHOSPHATE 
HC-succinate 
CONCENTRATION (mM) 
Fig. 6. The intestinal ring uptakes of hydrocortisone (HC-OH), hydrocortisone-21-succinate and hydrocorti- 
sone-21-phosphate as a function of concentration. Hydrocortisone is a saturated solution at 5 and 10 mM. The 
prodrugs are freely soluble in the concentration range studied. Each point represents the mean value of 3-15 
intestinal rings from 2-5 rats + SEM. 
lished results indicate that uptake of hydro- 
cortisone-21-succinate by proximal colon is in 
the form of the prodrug (>85% hydrocorti- 
sone-21-succinate). The concentration uptake 
rate profiles shown in Fig. 6 are similar to 
those presented for decanol and decyl ly- 
sinate, i.e., the uptake rate plateau dictated 
for hydrocortisone is evident beginning at 
its solubility concentration (0.77 m&Z) and 
continues throughout the concentration range 
studied. Uptake of the 21-phosphate and 
21-succinate prodrugs increases linearly with 
concentration. Ester stability in bulk incuba- 
tion media and under assay conditions was 
verified, which emphasizes the conclusion 
that enzymatic hydrolysis has occurred in 
concert with intestinal absorption. Hydro- 
cortisone uptake rates are compared with 
those of hydrocortisone-21-phosphate and 
hydrocortisone-21-succinate at 10.0 mM 
incubation media concentrations in Fig. 7. 
An order of magnitude difference in ob- 
served uptake rate is seen between the parent 
compound and prodrugs. 
Theoretical uptake rates can be estimated 
from the following solution for diffusion 
through a planar surface in semi-infinite 
media [22] , (Table 3) 
U, = 2C, [Dt/n]‘h(A/m) (7) 
where U~J, is the theoretical uptake rate, 
Co is the concentration of bulk solution, 
D is the diffusion coefficient [17], t is 
time = 120 s, and A/m is the area:mass cor- 
relation = 22.6 cm2/g wet tissue. A/m = 22.6 
cm2/g wet tissue was experimentally deter- 
mined and is in good agreement with values 
reported in the literature: 24.0 cm2/g [23] 
and 32.0 cm2/g [24] . The calculated values 
are compared with experimentally determined 
values in Table 3. The theoretical values 
range from 4 to 14X those observed in this 
study. The uptake model (eqn. 7) assumes 
sink conditions at the solution-brush border 
membrane interface, a planar surface, and 
a constant diffusion coefficient. Surface area 
effects, as well as a changing diffusion coeffi- 
cient, might explain these deviations. In an 
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Fig. 7. Logarithmic uptake rates by intestinal rings 
at 10 mM incubation medium concentrations of 
hydrocortisone, hydrocortisone-21-phosphate and 
hydrocortisone-21succinate. 
earlier study, decanol uptake was determined 
from 0.25-1.0 mA4 solutions [21]. When 
the results were normalized to Co = 0.15 r&M, 
the uptake was 55.8 nmol/min g dry tissue, 
closer to the theoretical rate in our study. 
This difference may be due to two factors. 
First, the concentrations used in the latter 
study were above the solubility of decanol; 
although no mention of precipitation was 
made, the possibility exists that a contribu- 
tion by suspended liquid droplets may have 
occurred. Secondly, these authors normalized 
uptake results by dry tissue weight. Since 
intestinal tissue is approximately 80% water, 
this may also account in part for the differ- 
ence between the two studies. While theo- 
retical and experimental values could be 
brought into closer agreement by either 
reducing the diffusion coefficient or relaxing 
the sink boundary condition at the mem- 
brane solution interface, the calculation 
demonstrates that the observed uptake is 
comparable to what would be expected 
theoretically. 
The approach taken in this report is based 
on the known role of brush border enzymes 
in peptide digestion and absorption [8, 25, 
261. Chemical derivatization of poorly water 
soluble compounds has been used to target 
sites favorable to intestinal absorption. It 
TABLE 3 
Theoretically predicted (Vu,) and experimentally observed (U,,) uptakes of all compounds are 
tabulated. Also shown are the estimated diffusion coefficients [ 171, and concentrations (C,) at 
which the rates were determined. Theoretical and experimental uptakes for the alcohols and 
steroids are not directly comparable as the former rates are normalized by wet tissue mass 
and the latter by dry tissue mass 
Compound C, 10h D fJth 
(mol/lOOO ml) (cm2/s) (nmol/g min) :Zrol/g min) 
Hexadecanol 200 nM 6.82 0.086 0.006 
Decanol 150 rM 8.87 73 6.5 
Hexadecyl lysinate 1mM 5.15 373 92 
Decyl lysinate 2 mM 5.98 805 125 
Hydrocortisonea 10 mM 7.22 8300 1330 
Hydrocortisone-2 1 -phosphate 1omM 5.07 5.77 x lo4 1.83 x lo4 
Hydrocortisone-2 1 -succinate 1OmM 4.68 5.55 x lo4 1.97 x 10’ 
=Uti for this saturated solution was calculated using C, = C, (37°C) = 1.10 mM. 
may be concluded that making water soluble 
prodrugs selective for membrane-bound di- 
gestive or metabolic enzymes systems in the 
gut can substantially improve the transport 
of water insoluble solutes into mucosal cells. 
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